...
首页> 外文期刊>Sequential analysis >Information Growth in a Family of Weighted Logrank Statistics Under Repeated Analyses
【24h】

Information Growth in a Family of Weighted Logrank Statistics Under Repeated Analyses

机译:重复分析下加权Logrank加权统计族的信息增长

获取原文
获取原文并翻译 | 示例
           

摘要

The use of group sequential methods has become standard practice in the clinical-trial setting. Because patients are not all generally entered into a clinical trial at the same time and due to delayed outcomes, interim analyses are typically planned with respect to statistical-information time rather than calender time. In many cases it is sufficient for interim testing to be based upon the number of responses observed, e.g., the number of patients for whom a post-randomization blood pressure had been measured or the number of patients surviving past a given time period. In the case of censored survival data, the logrank statistic is a commonly used tool for comparing the survival experience of two or more groups. Assuming equal randomization and the null-hypothesis of no difference in survival, it is well know that statistical information grows in proportion to the number of events observed, making analysis planning on the information scale trivial. However, when weighted versions of the logrank statistic are used, the number of censored observations at each analysis time is affected by both the enrollment rate and the timing of interim analyses. We describe how statistical information grows when testing of censored survival data is based upon selected members of the G~(ρ,γ) family of weighted logrank statistics under various enrollment scenarios that may be encountered in the clinical-trial setting. In addition, we consider the impact on estimation of treatment effects when performing an interim analysis at less than maximal information in the setting of nonproportional hazards survival data. A reweighting of the G~(ρ,γ) statistic is proposed that reapportions unused weight at interim analyses to a subset of the last observed events, thereby providing estimates of treatment effect obtained at interim analyses that are more comparable to those that would have been obtained had estimation been performed under full support.
机译:在临床试验中,使用团体顺序方法已成为标准做法。由于通常并非所有患者都同时在同一时间进行临床试验,而且由于结果延迟,因此通常会根据统计信息时间而不是日历时间来计划中期分析。在许多情况下,根据观察到的反应数量(例如,已测量随机化后血压的患者数量或在给定时间段内幸存的患者数量)进行中期测试就足够了。在审查生存数据的情况下,对数秩统计是比较两个或多个组的生存经验的常用工具。假设随机分组相等且生存率无差异的零假设,众所周知,统计信息与观察到的事件数量成正比增长,这使得信息规模的分析计划变得微不足道。但是,使用对数秩统计的加权版本时,每个分析时间的审查观察数受登记率和中期分析时间的影响。我们描述了在基于临床试验环境中可能遇到的各种入选情况下,基于加权对数秩统计的G〜(ρ,γ)族的选定成员时,对经过审查的生存数据进行测试时统计信息如何增长。此外,我们在设置非比例风险生存数据时,以少于最大信息量进行中期分析时,会考虑对治疗效果评估的影响。建议对G〜(ρ,γ)统计量进行重新加权,以将中期分析中未使用的权重重新分配给最后观察到的事件的子集,从而提供与中期分析相比具有更可比性的中期评估所获得的治疗效果的估计值。得到的估计是在全力支持下进行的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号